INTRODUCTION
Cockayne syndrome (CS) is a very rare autosomal recessive multisystem disorder belonging to the family of DNA repair diseases. Clinical features include progressive neurologic and sensory impairment, photosensitivity, cachectic dwarfism and a typical facial appearance. The disease is considered to be very likely if the major clinical criteria (growth failure, mental retardation) and at least three of the minor clinical criteria (photosensitivity, pigmentary retinopathy or cataract, deafness, dental caries, cachectic dwarfism) are present. The diagnosis is confirmed by biochemical (inhibition of RNA synthesis after ultraviolet irradiation in cultured skin fibroblasts) and genetic testing (mutation in the CSA/ERCC8 or CSB/ERCC6 genes, involved in DNA repair). The disease shows a wide spectrum of presentations and is divided into four clinical subtypes with regard to the age at onset and the severity of the disease. Cerebro-oculo-facio-skeletal syndrome (COFS) is the most severe form, starting in the utero with a rapidly fatal outcome. CS2 begins in the first few years of life and leads to death in infancy. CS1, considered as the classical and the most frequent form, begins in childhood with a fatal outcome in late childhood. CS3 shows milder clinical signs and follows a more protracted course into adulthood.
Brain imaging plays a crucial role in suggesting the diagnosis of CS. Brain white matter (WM) signal abnormalities on MRI, basal ganglia calcifications on CT and brain atrophy, predominantly in the posterior fossa, are cardinal features of the disease. A previous study described neuroimaging in CS and showed that CS is primarily a hypomyelinating disorder. 1 Striking differences in imaging were also found between the subtypes of the disease. The more severe types (CS2 and COFS) were characterized by early atrophy, severe hypomyelination and calcifications distributed in a particular pattern within the cortex and the subcortical WM as well as within the leptomeningeal vessels. In contrast, atrophy and hypomyelination were lower in the less severe form (CS3). Recently, van der Voorn et al 2 attempted to classify leukodystrophies into different groups using the magnetic transfer ratio (MTR), diffusion tensor imaging (DTI) and MR spectroscopy. 2 Apparent diffusion coefficient (ADC) values were close to normal values in hypomyelination and significantly increased in demyelinating disorders, vacuolating and cystic degeneration (p , 0.001). Fractional anisotropy (FA) was slightly but significantly decreased compared with controls in hypomyelinating disorders (p , 0.01) and highly decreased in demyelination, myelin vacuolation and cystic degeneration (p , 0.001).
Therefore, the aim of this DTI study in CS was first to determine the DTI parameters in CS and to characterize the CS subtypes based on DTI measurements; a volumetric brain analysis was also performed to quantify brain volume loss and to look for differences between subtypes. The second objective was to determine whether DTI findings may correspond to findings observed in patients with hypomyelinating disorders.
METHODS AND MATERIALS
Patients 14 patients with proven CS (13 genetically, 1 biochemically; 8 males, 6 females; age range, 1.5-28 years; mean age, 8.5 years) (Table 1) were enrolled in a prospective study and underwent brain MRI. Sedation with oral chloral hydrate was used when needed. There were two patients with CS3 (15 and 28 years old), seven patients with CS1 (6-16 years), three patients with CS2 (1.5-3 years) and two patients with COFS (2 years). 12 of them were included in a previous study. 1 The control group included age-and sex-matched typically developing subjects who underwent MRI for different reasons, such as headaches and orofacial mass. Brain MRI was retrospectively considered normal in these subjects. The local ethics review committee approved the study, and written informed consent was obtained for all participants or their legal guardians.
Imaging DTI and volumetric imaging were performed on a 1.5-T MRI scanner (Siemens Avanto, Erlangen, Germany) in patients and controls as part of a complete brain MRI examination that also included sagittal T 1 weighted [repetition time (TR)/echo time (TE)/excitations/acquisition time, 452 ms/9 ms/1/1 min 43 s, axial proton density and T 2 weighted (TR/TE/excitations/acquisition time, 4000 ms/14-109 ms/1/2 min 42 s) and fluid-attenuated inversion-recovery (TR/TE/inversion time/excitations/acquisition time, 9290 ms/116 ms/2500 ms/1/3 min 56 s) images]. Volumetric imaging was obtained from a three-dimensional fast low-angle shot axial T 1 weighted sequence (TR/TE/excitations/acquisition time, 11 ms/4.94 ms/1/5 min 34 s; field of view 25 cm, matrix 224 3 256 pixels; 176 slices; voxel 1 3 1 3 1 mm, gap 20%). DTI was acquired in the axial plane (TR/TE/flip angle, 6800 ms/99 ms/ 90°, field of view 5 230 mm, matrix 5 128 3 128 pixels, section thickness/intersection gap 3.5 mm/0, number of excitations 5 2, resulting in a voxel size of 1.8 3 1.8 3 3.5 mm 3 ). Diffusionsensitizing gradient encoding was applied sequentially in 30 non-collinear directions with 2 b-values (b 5 0-700 s mm 22 ,4 years, b 5 0-1000 s mm 22 .4 years); 41 axial slices of 3.5-mm thickness covering the whole brain were acquired in 7.1 min in all patients. In patients who were young with small brains, the uppermost slices were located outside the brain and were not included in post-processing. Criteria for inclusion in the study were defined as an MRI study free of motion artefacts.
Data post-processing
Brain diffusion tensor imaging analysis 10 of the patients had a good-quality DTI sequence and could be analyzed with regions of interest (ROIs), first with whole-brain analysis and then left semiovale centre analysis. The DTI sequence did not include the posterior fossa in two of these patients. The FA, ADC maps and DTI eigenvalues were computed from DT images using the proprietary software of the scanner manufacturer (Neuro3D, Siemens Healthcare, Erlangen, Germany).
Whole-brain analysis The distribution of DTI indices (FA and ADC) (expressed as mean 6 standard deviation) was analyzed over different brain ROIs manually defined on the axial b0 Figure 1 ). All ROIs were drawn bilaterally except for the CC and the pons. The size of the circular ROI was adjusted to the volume of the structure studied. ROIs were placed away from calcifications within the WM by referring to the CT scan. The basal ganglia and thalamus were not analyzed because calcifications were frequent in these locations, which could alter the results, particularly ADC values ( Figure 2 ).
Left centrum semiovale analysis In the second step, a single ROI was placed in the left CSO with calculation of the ADC, FA, axial (l 1 ) and transverse diffusivity (l t 5 (l 2 1 l 3 )/2) first to compare the main diffusion indices (ADC and FA) with the van der Voorn et al 2 study and second to gain insight into the pathogenesis of WM alteration with DTI eigenvalues.
Brain volumetric analysis
All 14 patients were analyzed. Total brain volume and infratentorial volume (ITV) (brainstem and cerebellum) were obtained by applying in-house-implemented segmentation software (Medimax-Medipy, http://piiv.u-strasbg.fr/traitementimages/medipy) with automatic and manual segmentation, performed by the first author. Massive calcifications of the basal ganglia were excluded by the segmentation tool, as the cranial bone, because they were both recognized as bone tissue. However, lighter and cortical calcifications were not distinguished from brain parenchyma by the software. The boundary of the infratentorial area was delineated according to previous publications. 3 The volume of each part of the brain was calculated by quantifying the number of voxels present. ITV was also normalized to total brain volume to estimate ratios.
Statistical analysis Brain diffusion tensor imaging analysis
Whole-brain analysis The DTI parameters of patients with CS and controls were compared for each ROI for FA and ADC using the Student's t-test. A p-value ,0.05 was considered significant. Two groups were then created to compare the DTI parameters between patients with CS because of the small number of patients within each CS subtype. The moderate group included patients with CS1 and CS3 (six patients) and patients with severe CS2 and COFS (four patients). To examine group differences, the Student's t-test was applied for each ROI in each subgroup for FA and ADC. A p-value ,0.05 was considered significant.
Left centrum semiovale The FA, ADC, l 1 , l 2 , l 3 and l t values of the patients with CS were obtained. After logarithmic transformation, the values were compared with controls using the Student's t-test with a p-value ,0.05 considered significant.
Brain volumetric analysis
After logarithmic transformation, brain volumes were compared between patients with CS and controls and between the CS3 1 CS1 and CS2 1 COFS groups using the Student's t-test.
A p-value ,0.05 was considered significant.
RESULTS

Brain diffusion tensor imaging analysis Whole-brain analysis
Comparison between patients with Cockayne syndrome and controls A significantly (p , 0.05) decreased FA and increased ADC was found in patients with CS compared with controls within the FWM and temporal WM, CSO, genu and splenium of the CC (Table 2) . A significantly increased (p , 0.05) ADC was also seen in patients with CS within the internal capsules, cerebellar peduncles and cerebellar hemispheres. The greatest ADC differences between patients and controls were found in the CC and CSO (Figure 3 ).
Comparison between groups of patients with Cockayne syndrome Statistical analysis revealed significant and nonsignificant group differences in DTI indices ( Considering DTI parameter values with increasing age, absolute ADC values were steady, while FA values were lower, and all three eigenvalues and l t were higher.
Brain volumetric analysis Total brain volume was significantly reduced in patients with CS compared with that in controls by 57.06 6 9.5% (mean 6 standard deviation) ( Table 5 ). The brain volume reduction was greater in the posterior fossa (68.68 6 11.9%) than in the supratentorial area (55.3 6 9.7%), with an ITV normalized by total brain volume in patients with CS (8.9 6 1.9%) significantly lower than that in controls (12.5 6 1%). Total brain volume loss was significantly higher in the severe type of CS (CS2 and COFS) (65.8 6 6.3%) than in the moderate type (CS3 and CS1) (52.2 6 9.1%) (Figure 4) . No statistical differences were observed for infratentorial brain volume normalized by total brain volume between the CS2/COFS (8.70 6 1.57%; mean age, 2 years) and CS1/CS3 subgroups (9.09 6 2.16%; mean age, 9 years).
DISCUSSION
This study compared the DTI metrics and brain volume of patients with CS and controls. Significant differences were observed between CS and controls and between CS subtypes. DTI metrics showed lower FA values and higher ADC values in most WM structures in patients with CS. The ADC and eigenvalues were consistent with hypomyelination. Brain volume loss reached 50% and was predominant within the posterior fossa.
Diffusion tensor imaging analysis
Hypomyelinating disorders are the largest subgroup of leukodystrophies of unknown origin. 4 Like other hypomyelinating diseases, CS manifests as an aspecific, diffuse, moderate high signal intensity of the supratentorial WM on T 2 weighted imaging, with intermediate or slight high signal intensity on T 1 weighted imaging. 5, 6 Additional imaging findings may help in the diagnosis of CS, such as basal ganglia calcifications and brain atrophy predominant in the posterior fossa, but the diagnosis remains difficult if these are lacking. Moreover, the prognosis differs widely between the different CS subtypes, which may be difficult to discriminate clinically because of overlapping features. 7 Conventional imaging with T 1 weighted imaging and T 2 weighted imaging helps discriminate CS subtypes. 1 However, A previous study combining quantitative parameters from MR spectroscopy, MTR and DTI 2 showed that ADC was not statistically different from controls in the hypomyelinating group of patients, but showed a statistically significant increase in creatine (p , 0.5) and myo-Inositol (p , 0.001) and a decrease in MTR (p , 0.001) and FA (p , 0.01). The present study showed statistically significant differences for both ADC and FA values obtained within the CSO (p , 0.001) between patients with CS and controls, with an increased mean ADC value in patients with CS (1179.2 3 10 26 mm 2 s 21 6139.86). The statistically significant differences in ADC values in our study may be explained by the lower mean ADC values in controls in the present study compared with the study of van der Voorn et al, possibly related to the fact that controls and patients were strictly age and sex matched. The mean ADC value in patients with CS is close to the hypomyelination category reported by van der Voorn et al 2 and to the values observed during normal brain development in 6-month-old infants 11 and 2-to 4-monthold infants. 12 This suggests that CS is a hypomyelinating Table 4 . Diffusion tensor imaging analyses on the left centrum semiovale: comparison between patients with Cockayne syndrome (CS) and controls COFS, cerebro-oculo-facio-skeletal syndrome; ITV, infratentorial volume; STV, supratentorial volume; WBV, whole-brain volume.
Values are expressed as mean 6 standard deviation. p value ,0.05 was considered significant.
Full paper: Cockayne syndrome: an MRI study BJR disorder. However, secondary destruction of myelin may also contribute to high ADC values in CS, although ADC would be higher and associated with a low T 1 signal intensity. Multimodal MRI including DTI, the recently developed myelin water fraction mapping technique and MTR may better assess myelination in CS. 13 Although longitudinal MRI follow-up was not available, ADC values found in the CSO were stable with increasing age. Conversely, FA values in the CSO decreased with increasing age, and mean FA values were close to demyelinating disorders. 2 These findings could be explained by the progressive atrophy observed over time in CS. In the hypomyelination category in the study of van der Voorn et al, FA was only slightly decreased, contrary to the demyelinating category, and atrophy was not reported as a significant finding. Indeed, the main source of WM anisotropy is not myelin integrity, but much more axonal cellular membrane integrity and fibre density/compaction/alignment, 14 which are affected in both demyelinating disorders and atrophy. However, the comparison of our data with those of van der Voorn et al is limited, as the technical parameters and processing of DTI were not strictly the same. DTI metrics showed lower FA values (p , 0.05) and higher ADC values (p , 0.05) in most brain structures in patients with CS, even in those unaffected by signal abnormalities such as cerebellar peduncles. The greatest ADC differences between patients and controls were found in the CC, CSO and FWM, while the greatest FA differences were observed in the CC, parietal and FWM and CSO. This correlated well with conventional MRI as those areas showed high T 2 signal intensities in patients with CS. DTI was even more sensitive by detecting abnormalities not apparent on conventional MRI in the cerebellum and pons.
In terms of severity, DTI metrics showed statistically significant differences (higher ADC, lower FA values) (p , 0.05) in severe cases compared with moderate cases within the CC splenium and PLIC (ADC), and in the cerebral peduncles (FA). This is concordant with the different signal intensities observed on conventional MRI in the different subtypes in these structures. Indeed, a high T 2 signal intensity was observed within central WM tracts (internal capsule and CC) in the more severe CS groups in a previous study, 1 indicating absent myelination, while a low signal intensity was present in the less severe group, indicating myelination. Moreover, DTI showed FA differences in the cerebral peduncles that were not detected by conventional MRI. The differences found between CS subtypes should be interpreted with caution owing to the small number of patients, but this demonstrates that DTI provides an objective and quantitative imaging marker of severity in CS and is slightly more sensitive regarding CS subtype distinction than conventional MRI. Even if DTI seems slightly more sensitive than conventional MRI to detect WM abnormalities in patients with CS and between CS subtypes, the additional information is not really relevant. Also, the patients included in this study were very young, so prolonged MRI examinations with DTI are not desirable. One of the potential advantages of DTI in CS may be monitoring of therapeutic intervention closely.
Two directional parameters can be extracted from DTI: axial diffusivity and radial or transverse diffusivity. 15 Animal models and DTI/post-mortem histology correlations have demonstrated that these parameters are non-invasive markers of axons (integrity/compaction) and myelin sheaths (demyelination/ remyelination), respectively. 16 In our study, axial and moreover radial diffusivity values were significantly increased in the CSO (p , 0.001). These DTI parameter modifications in CS were close to those observed in a mouse model of PelizaeusMerzbacher disease, 8 which were attributed to astrocyte hypertrophy (reactional gliosis) and myelin defects, respectively. Striking similar neuropathological findings were observed in CS, consisting of diffuse cerebral and cerebellar WM atrophy with a discontinuous multifocal myelination defect and fibrillary gliosis in myelin-defective zones.
17,18
The pathophysiology of myelin abnormalities in CS is ascribed to both neurodevelopmental failure and neurodegeneration. Initially, a transcriptional defect leads to a low amount of myelin produced by oligodendrocytes, which could explain the hypomyelination observed on imaging. The small amount of myelin may be of poor quality and spontaneously broken down progressively or by defective maintenance by oligodendrocytes that disappear owing to apoptosis related to an accumulation of DNA errors. 19 This could explain the progressive atrophy/shrinkage of the WM observed on imaging, as in all end-stage leukodystrophies. 20 Brain volumetric analysis Overall, we found significant brain atrophy/volume reduction in patients with CS compared with healthy controls (p , 0.001). This was closely correlated with the profound microcephaly usually observed in all patients beyond 2 years of age. Our mean value of 57 6 9.4% brain volume reduction concurs with pathological studies, reporting .50% brain atrophy, mainly in the WM. 21, 22 Brain atrophy was greater in patients with CS2 and COFS than that in patients with CS3 and CS1 (p , 0.001). This is also in accordance with neuropathological reports and with the more severe microcephaly observed in CS2 and COFS. 18, 23 Predominant atrophy/volume reduction in the posterior fossa confirms previous pathological CS studies. 24 Clinically, it correlates with the cerebellar syndrome observed consistently in patients with CS. 7 Prominent cerebellar atrophy could be explained by combined atrophy/volume reduction of the cerebellar cortex and WM, while WM atrophy is predominant in the supratentorial area. 17, 22, 25 The pathophysiological background of selective vulnerability of the cerebellar cortex may be based on ongoing neuronal proliferation, particularly for granule cells in the external granular layer, during the first year of life, which explains postnatal cerebellar enlargement. 26 Atrophy is a nonspecific finding that occurs at the end-stage of many leukodystrophies. However, progressive severe atrophy, predominantly in the posterior fossa, is observed in few leukodystrophies apart from CS and is a common sign of DNA repair diseases such as CS, xeroderma pigmentosum and ataxia-telangiectasia. 27 We did not find statistically significant differences between the two severity groups, COFS/CS2 and CS1/CS3, concerning the degree of the infratentorial brain volume atrophy/volume reduction relative to total cerebral volume. This may indicate that the pathophysiological mechanism of volume reduction applies equally to the infratentorial and supratentorial areas in both groups.
Limitations of the study
The main limitations of this study are the small number of patients with analyzable data owing to the rarity of CS, the wide age distribution and the cross-sectional design of the study; these factors limit the conclusions drawn from this study. We used a 1.5-T MR scan. Higher field strength 28 and multishell diffusion imaging 29 could provide more accurate and specific data about pathological WM structure. Another technical limitation of the study lies in the different b-values used for patients under 4 years of age (b 5 700 s mm -2 ) and after 4 years of age (b 5 1000 s mm -2 ), limiting the comparisons between the groups, knowing the b-value dependence of DTI parameters quantification. 30 Concerning DTI data analysis, we used ROI analysis, but a voxel or tract-based statistical analysis could have provided more robust and informative data on specific tract systems. However, those techniques could not be used because of the differences in brain size and major WM atrophy of patients with CS. 31 The reproducibility of the brain volume measurements depends on the software segmentation tool used, imaging hardware and acquisition parameters, making comparisons between studies difficult. However, given the relatively high volumetric differences observed between patients with CS and controls, minimal differences would be observed between software programs. A complementary longitudinal study evaluating more patients would provide additional information on the temporal dynamics of DTI parameters as well as brain volume loss in CS.
CONCLUSION
Our findings demonstrate that DTI-derived metrics and volumetric analysis provide quantitative information for the characterization of CS. Compared with conventional MRI, DTI is slightly more sensitive for the detection of WM abnormalities in CS and in the distinction of CS subtypes. Even if DTI does not seem essential for the diagnosis and distinction of CS subtypes, these complementary quantitative data may be particularly useful for monitoring therapeutic intervention.
